aceWhat Users Say About Reimbursable Digital Therapeutics in Germany: Large-Scale App Store Review Analysis Using a Large Language Model
Background In 2019, Germany introduced a unique regulatory framework for digital therapeutics (DTx), termed digital health applications (DiGAs) in Germany, with the goal of integrating evidence-based DTx into statutory health care. DTx are eligible for reimbursement by statutory health insurance if manufacturers demonstrate positive health care effects, such as improved health status or health literacy, in a controlled study setting. Although regulatory evaluation primarily relies on manufacturer-conducted studi…
GPT-4o classified user statements from DiGA app reviews with high accuracy, letting researchers surface user-centered real-world evidence to complement formal manufacturer-led evaluation.
The same review analysis found that login, registration and technology problems are overwhelmingly negative, pointing to persistent barriers to accessing and using reimbursed DiGAs.
Evidence
- Peer-reviewedJMIR Human Factors2026-10-08
How should this claim be treated?
Truvace Impact Record TRV-2026-1703, v1: “What Users Say About Reimbursable Digital Therapeutics in Germany: Large-Scale App Store Review Analysis Using a Large Language Model.” Truvace, 2026-10-17. /record/TRV-2026-1703 (accessed at citation time). sha256 8aa101f71249fbb1…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1703 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.